Bristol Myers Squibb (BMY) wins dismissal of a lawsuit filled by Blue Cross Blue Shield of Louisiana alleging antitrust trust ...

Bristol Myers Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing ...

Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...

Ericsson joining Avanci Video as a licensor and the EUIPO's plans for AI use were also among the top talking points this week ...

Morgan Stanley lowered the firm’s price target on Bristol Myers (BMY) to $36 from $37 and keeps an Underweight rating on the shares. The firm ...

Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...

Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing sham patent ...

Bristol Myers Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing sham patent lawsuits to maintain an illegal monopoly on its blockbuster ...

Shares of biopharmaceutical company Bristol Myers Squibb (BMY) were in the spotlight on Wednesday morning after the company ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...